These Terms and Conditions, together with each Order Form, any applicable Schedule, the DPA, AUP and SLA, all as updated from time to time by Accurx, form the Agreement between Licensee and Accurx. Licensee acknowledges and agrees that these documents apply to any use of the Platform by Service Recipients and Authorised Users.
The Schedules form part of the Agreement where they are stated to apply in an Order Form, or where their application criteria are otherwise met. Each Order Form may identify the Schedules that apply to the relevant Products, but failure to list a Schedule does not prevent that Schedule applying where a Service Recipient or an Authorised User accesses or uses Products, features or functionality described in that Schedule
By executing an Order Form referencing these Terms and Conditions, or by accessing or using the Products, the Licensee agrees to be bound by the Agreement.
In the event of any conflict or inconsistency between the provisions of any document which form part of the Agreement, the order of precedence for resolving such conflict is:
the Order Form;
the DPA in respect of any rights, obligations or liability in relation to Personal Data; and
each Schedule in respect of its specific subject matter only.
the Terms and Conditions.
Capitalised terms not defined within these Terms and Conditions shall have the meanings, and the rules of interpretation that apply to this Agreement shall be as, set out in Schedule 1.
If an authorised Commissioning Organisation (such as an Integrated Care Board or PCN) procures access to and use of the Platform on behalf of Licensee and any Service Recipients through a separate agreement with Accurx (“Commissioning Contract”), the provisions in Schedule 2 shall apply.
For the avoidance of doubt, the AUP and the Privacy Notice shall apply at all times to all users of the Platform (i.e. Authorised Users and Authorised Free Users), regardless of whether the Agreement is between Accurx and the Authorised Free User (as Licensee) or Accurx and an organisation (as Licensee, Commissioning Organisation or Service Recipient) or as part of Free Services.
Licensee may submit an Order Form to Accurx. Following submission of an Order Form, the Terms and Conditions shall become effective and Licensee shall not be entitled to amend or withdraw such Order Form. In the event there is no Order Form, the Terms and Conditions shall become effective and binding on Licensee when Licensee, or one of its Authorised Users, creates an Account.
Accurx may accept, propose amends to, or reject an Order Form in its absolute discretion.
No variation to an Order Form shall be binding unless expressly agreed in writing by Accurx.
Where Accurx agrees to provide the Platform on the basis of a Free Services, the terms set out in Schedule 3 shall apply.
Licensee agrees and confirms that:
it and its signatory are duly authorised to enter into this Agreement on behalf of Licensee and any other Service Recipients;
by continuing to use and access the Platform, it agrees to be bound by the latest version of the Terms and Conditions; and
if it elects to use a new Product, such use and access will be covered by, and the relevant Product will be added to, this Agreement in accordance with clause 3.
Subject to payment of the Charges and compliance with the Agreement, Accurx hereby grants to Licensee a non-exclusive, non-transferable right (with a limited right to sub-license to Service Recipients) to access and use the Platform and Documentation during the Term in accordance with the Agreement.
The licence granted in clause 5.2 shall be for the Authorised Use only and Licensee:
undertakes to access and use the Platform in accordance with the AUP; and
agrees to bring the AUP to the attention of Service Recipients and Authorised Users and ensure that all Service Recipients and Authorised Users access and use the Platform in accordance with the AUP.
Licensee shall at all times not, and shall procure that any other Service Recipients and all Authorised Users shall at all times not, knowingly access, store, distribute or transmit any Viruses or any material during the course of their use of the Platform that contains profanities or expletives, is unlawful, harmful, abusive, infringing, offensive, discriminatory, or which facilitates illegal activity or depicts sexually explicit images or causes damage or injury to any person or property. Accurx reserves the right, in its sole discretion and without liability or prejudice to its other rights to Licensee, to:
remove any such material and to suspend or disable Service Recipients' and Authorised Users' access to the Platform at any time and for any reason, including without limitation any actual or suspected breach, if Service Recipients and/or Authorised Users breach this clause 5 or the AUP;
report any misuse of the Platform by Authorised Users in contravention of the AUP to the relevant Service Recipient;
report any misuse of the Platform by the Authorised Free Users in contravention of the AUP to the relevant organisation that engages the HCP; and/or
report any evidence of serious and frequent misuse by Service Recipients and Authorised Users or the Authorised Free Users to relevant authorities and regulators as required.
Except as expressly permitted by the Agreement or by applicable law which cannot be excluded, Licensee shall not, and shall procure that each Service Recipient and Authorised User shall not, attempt to copy, modify, duplicate, create derivative works from, frame, mirror, republish, download, display, transmit, or distribute all or any portion of the software underpinning the Platform in any form or media or by any means; or attempt to reverse compile, disassemble, reverse engineer or otherwise reduce to human-perceivable form all or any part of the Platform.
Licensee shall not, and shall not attempt to (and procures that each Service Recipient and Authorised User shall not and shall not attempt to):
access all or any part of the Platform in order to build a product or service which competes with the Platform;
make the Platform available to any third-party (except to other Service Recipients and Authorised Users); or
attempt to obtain, or assist third parties in obtaining, access to the Platform, other than as provided under this clause 5.
Licensee shall, and shall procure that its Service Recipients and Authorised Users shall,:
use all reasonable endeavours to prevent any unauthorised access to, or use of, the Platform and, in the event of any such unauthorised access or use, promptly notify Accurx;
keep a secure password for their use of the Platform only and shall procure that each Authorised User shall keep their password confidential and not share their login credentials with anyone else;
use an individual email address when creating an Account and not use generic or team email addresses (such as muscoskeletal@trust.nhs.net or info@gppractice.nhs.net);
safeguard access to the devices used to access the Platform; and
inform Accurx immediately if they suspect any unauthorised access to their Account.
Accurx shall not be liable for any delay, failure or breach of these Terms and Conditions where Licensee does not provide such authority, information and co-operation or Licensee fails, delays or omits to act in respect of any of its obligations under these Terms and Conditions.
Except as expressly provided in this Agreement, Accurx makes no warranties, express or implied, including any implied warranties of merchantability or fitness for a particular purpose, and all other warranties, representations, conditions and terms of any kind implied by statute or common law are, to the fullest extent permitted by applicable law and without limitation, excluded from this Agreement. The Platform, the Documentation and any other materials or services are provided to Licensee on an 'as is' basis.
Accurx Scribe fair usage: Licensee acknowledges that Accurx Scribe is subject to fair usage limitations in order to prevent system overload, ensure service quality for all users and ensure licences are not being misused or shared between Authorised Users. Such usage limitations are based on the relevant access for Service Recipients as set out and accessible https://support.accurx.com/en/articles/4453468-accurx-lite-vs-accurx-plus-what-are-the-differences (as may be updated from time to time during the Term by Accurx). Usage exceeding this limit is not possible and no further transcriptions can be made by that Authorised User for the remainder of the day. There are no concurrency limits or incremental charges associated with this usage cap.
Each Party shall comply with its respective obligations under the Data Protection Legislation and shall process Personal Data under the terms of the DPA and Privacy Notice (as applicable).
Each Service Recipient shall own all right, title and interest in and to all of its relevant Service Recipient's Data and the Patient Data. Licensee shall have sole responsibility for the legality, reliability, integrity, accuracy and quality of Service Recipients' Data and Patient Data.
Accurx may use Service Recipient Data and other usage data and information related to the use of the Platform during the Term to create Analytical Data, which Licensee acknowledges may be used to improve the performance and functionality of the Platform or develop Improvements.
Accurx may track and analyse Service Recipients' and Authorised Users' use of the Platform for the purposes of security, service delivery, auditing and to help Accurx improve the Platform.
Accurx shall abide by and make the Platform available substantially in accordance with the SLA, as relevant to the Products to which Service Recipients and Authorised Users have access, and provide the level of user support set out in the SLA.
Accurx shall not be liable for any breach of its obligation in clause 7.1 to the extent any non-conformance is caused by use of the Platform contrary to Accurx’s instructions, or any modification or alteration of the Platform by any party other than Accurx. Notwithstanding the foregoing:
Licensee acknowledges and agrees that the Platform will evolve over time and that functionality may be added and removed from time to time, provided that such updates do not result in a material degradation of the overall functionality or performance of the Platform;
Accurx does not warrant that Service Recipients' and Authorised Users’ use of the Platform will be uninterrupted or error-free, or that the information provided, generated, obtained or otherwise accessible by Service Recipients through their use of the Platform ("Content") will meet Service Recipients’ requirements. For the avoidance of doubt, all Content is provided on the basis of the warranty disclaimer in clause 5.9 and Accurx assumes no responsibility for, and expressly disclaims any liability arising from use of or reliance on, such Content; and
Accurx shall not be in breach of the SLA to the extent any non-conformance relates to any loss in availability, delays, delivery failures, or any other loss or damage resulting from the transfer of data over third party communications networks, services and facilities that it does not own or that are out of its control (for example, the internet and any integrations such as electronic patient records and PDS), and Licensee acknowledges that the Platform may be subject to limitations, delays and other problems inherent in the use of such communications facilities;
Accurx shall not be liable for any unauthorised access, use or alteration of Authorised Users’ Accounts, transmissions or content, or any Virus or malware infecting Authorised Users’ devices as a result of the Platform to the extent that these arise from any use contrary to this Agreement and/or any instructions received from Accurx.
Accurx shall use the latest versions of anti-virus software available from an industry accepted anti-virus software vendor to check for, contain the spread of, and minimise the impact of Viruses.
This Agreement shall not prevent Accurx from entering into similar agreements with third parties, or from independently developing, using, selling or licensing documentation, products and/or services which are similar to those provided under this Agreement.
Licensee shall, and shall procure that each Service Recipient and Authorised User shall, abide by the Caldicott Principles, NHS Code and NHS Constitution while accessing and using the Platform. Licensee agrees that it is responsible for obtaining and maintaining all licences, permissions and consents (including under its own privacy notices and the common law duty of confidentiality) which may be required in order to implement, use, and submit Personal Data and any other data through the Platform.
Licensee shall provide Accurx with all necessary cooperation in relation to this Agreement and all necessary access to information as may be required by Accurx to fulfil its obligations under this Agreement, including granting Accurx full and unrestricted access to Licensee's and the other Service Recipients' account information and activity held internally by Accurx (for clarity this is not access to the Account) in order to allow Accurx to undertake activities such as providing support, carrying out maintenance, reviewing analytics and data to provide insights for making improvements to the Platform and fixing any errors. Licensee shall carry out all of its responsibilities in this Agreement in a timely and efficient manner.
Licensee shall be responsible for setting the access rights for its Authorised Users, and shall procure that each Service Recipient sets the access rights for its Authorised Users. Licensee acknowledges that Accurx will assign Administrator Privileges to the first Authorised User who accesses and/or creates a Workspace within the Platform (unless instructed otherwise in writing) and agrees that it is responsible for: (i) ensuring that any Authorised User with Administrator Privileges has been correctly assigned; and (ii) for making any changes and reassigning Administrator Privileges, as necessary.
Licensee shall ensure that all Service Recipients and Authorised Users use the Platform strictly in accordance with this Agreement and the AUP and shall be responsible for any Service Recipient's or Authorised User's breach of this Agreement and/or the AUP.
Licensee acknowledges that:
use of the Platform is subject to the Disclaimers;
use of certain Products is subject to the Product Specific Terms;
use of any AI Features is subject to the AI Services Schedule; and
certain Products are Medical Devices that have specific Medical Device Information which Licensee, Service Recipients, and Authorised Users must read and comply with before use, in accordance with Medical Device Legislation,
Licensee confirms that it understands and agrees, and procures that all Service Recipients and Authorised Users understand and agree, to the Disclaimers, the Product Specific Terms and the Medical Device Information, as applicable to the Products they use. Licensee further agrees to bring the Disclaimers, Product Specific Terms, and Medical Device Information to the attention of all Service Recipients and Authorised Users.
Licensee shall indemnify Accurx against all costs, losses, damages, liabilities and claims, arising from or in relation to any third-party claims (including claims for clinical negligence) as a result of the actions of Service Recipients or Authorised Users in providing their services to Patients using the Platform (including any failure by Service Recipients or Authorised Users to adhere to and follow the Disclaimers, Product Specific Terms, or Medical Device Information). In connection with any event reasonably likely to give rise to a liability under the indemnity in this clause 8.6, Accurx shall give Licensee written notice of any claim as soon as reasonably practicable.
Licensee shall ensure that its network and systems and those of the other Service Recipients comply with the Minimum Specifications as necessary for the operation of the Platform, and shall be solely responsible for procuring and maintaining all network connections and telecommunications links from its systems to Accurx’s data centres.
During the Term and for a period of one year afterwards, Licensee shall maintain in force insurance policies or indemnity schemes with reputable insurance companies or providers, against all risks that would normally be insured against by a prudent businessman in connection with the risks associated with this Agreement and the provision of direct care services to Patients (including without limitation for medical negligence), and shall produce to Accurx on request full particulars of that insurance and evidence that such insurance is current and in effect. Licensee shall procure that the other Service Recipients comply with this clause 8.8 in respect of their risks.
From time to time Accurx may ask that Service Recipients allow Accurx employees to attend Service Recipients’ premises to take part in, for example, a visit to a GP practice or NHS Trust hospital (“Practice Visits”), subject to the consent of Service Recipients. Accurx employees use the Practice Visits as an opportunity to shadow NHS staff to learn more about the challenges faced by healthcare professionals working in the NHS and to receive feedback or insight to guide improvements to the Platform and the development of new products. Accurx will arrange the Practice Visits with Service Recipients directly, at a time and frequency that is convenient to them, and Licensee procures that Service Recipients will accommodate the Practice Visits where possible.
Licensee shall update Accurx as soon as practical if there are any changes to the name or contact details of the Key Contact or any other individuals identified in the Order Form. Licensee acknowledges and agrees that until such notification is received, Accurx will continue using and contacting the existing individual and contact details.
This clause 9 only applies if access to the Platform is being paid for by Licensee and does not apply to Authorised Free Users.
Licence Fee
The Licence Fee is set out in the Order Form and Accurx agrees not to increase the Licence Fee during the Initial Term unless: (i) otherwise agreed in the Order Form; or (ii) Licensee procures additional access to the Platform in accordance with clause 9.2.3. For the avoidance of doubt, SMS Costs are not included in the Licence Fee and are subject to increase during the Term as set out in clause 9.4.3.
Without prejudice to clause 9.2.1, Licensee shall permit, and shall procure that the other Service Recipients shall permit, Accurx to monitor the Platform in order to establish how many Authorised Users and Patients are using the Platform. If Licensee exceeds the access rights set out in the applicable Order Form (for example, if Licensee has a different Patient list size or more Authorised Users than agreed), Licensee and Accurx shall promptly execute a new Order Form for such additional access rights.
Licensee may purchase access to the Platform for additional Patients, Authorised Users and/or Service Recipients (as applicable) during the Term.
Where Products have been purchased at a bundled price, Accurx will charge the Licence Fee for each module pro-rata according to the bundled price and invoice date.
Except as expressly provided in this Agreement, Charges are non-refundable other than in Accurx's sole discretion.
Payment
During the Term, Licensee agrees to pay Accurx the Charges by the due date and in accordance with the Payment Terms (both as set out in the Order Form) and will be charged these from the Switch-on Date (unless stated otherwise in the Order Form).
The Charges are stated exclusive of value added tax, which shall be added to the relevant invoice(s) at the appropriate rate where relevant.
Service Recipients remain responsible for payment of SMS Costs in the event an SMS message is sent via an SMS gateway that is not Accurx’s gateway (for example, an ICB’s SMS gateway) and that gateway is unable to deliver successfully an SMS Fragment and Accurx’s SMS gateway is required to deliver successfully the SMS Fragment(s).
Price increases
Subject to clauses 9.2.1 and 9.4.2, Accurx shall be entitled to increase:
the Licence Fee upon at least ninety (90) days’ prior written notice to Licensee with such increase taking effect at the start of the Renewal Term immediately following expiry of the notice; and
Accurx shall be entitled to increase the SMS Costs (in line with any third party supplier price changes passed on to Accurx) upon at least sixty (60) days’ prior written notice to Licensee. For the avoidance of doubt, increases to SMS Costs shall take effect immediately following expiry of the notice and not at the start of a Renewal Term.
For the avoidance of doubt:
Accurx does not need to provide the notice in clause 9.4.1 if the events in clauses 14.3 and 14.4 occur; and
should Licensee not wish to accept a SMS Costs price increase, it may terminate this Agreement by providing written notice to Accurx within thirty (30) days of being notified about the relevant price increase.
Consequences of non-payment
If Accurx has not received full payment of the Charges:
from Licensee within 30 days of the due date;
in accordance with clause 9.6.2 and payment remains outstanding 90 days from the original due date; or
in accordance with clause 9.7.2 and payment remains outstanding 90 days from the original due date,
Accurx shall be entitled to suspend access to the Platform for Licensee and any Service Recipients and Authorised Users (as applicable) on not less than 10 Business Days’ notice, until payment of the outstanding amount has been received by Accurx in full, without prejudice to any other rights and remedies of Accurx.
Interest shall accrue on a daily basis on any overdue amounts at an annual rate equal to 4% above the Bank of England's base rate, commencing on the due date and continuing until fully paid, whether before or after judgment.
Commissioning Organisation
Licensee’s Agreement with Accurx shall not automatically terminate in the event of a Commissioning Organisation entering a subsequent agreement with Accurx on behalf of Licensee.
If Accurx has not received payment by the relevant due date from Commissioning Organisation of any Charges which relate to Licensee's access to the Products and use of the Platform, Licensee shall pay the outstanding Charges in full, without prejudice to any other rights and remedies of Accurx.
Charges paid directly by Service Recipients
This clause 9.7 shall only apply where it is agreed in the Order Form that Service Recipients shall pay Accurx the Charges directly. In this event, Licensee shall procure that those Service Recipients pay Accurx the Charges as set out in the Order Form.
If Accurx has not received payment from the relevant Service Recipients of any Charges by the relevant due date, Licensee shall pay the outstanding Charges in full, without prejudice to any other rights and remedies of Accurx.
Licensee shall, and shall procure that Service Recipients and Authorised Users shall, comply with all applicable laws and regulations in the exercise of its rights and the performance of its obligations pursuant to this Agreement, including in relation to the Services Recipients' and Authorised Users' access or use of the Platform.
Accurx shall comply with all applicable laws and regulations in the exercise of its rights and the performance of its obligations pursuant to this Agreement.
As between the Parties, all rights (including Intellectual Property Rights), title and interest in and to the Platform, the Products, the Documentation, Analytical Data, and the Case Study shall belong to, and remain vested in, Accurx at all times.
Service Recipient grants Accurx a royalty-free, non-exclusive, non-transferable, sub-licensable licence during the Term to host, copy, process, transmit, display and use the Service Recipient Data solely to the extent necessary to provide the Platform and related services and to perform Accurx’s obligations under the Agreement.
Accurx may use and exploit, without any payment or attribution obligation of any kind, any feedback, suggestions, or ideas Service Recipients or Authorised Users provide to Accurx in connection with the Agreement or the Platform, including any such feedback, suggestions, or ideas provided during a Practice Visit (“Feedback”). To the extent permitted under applicable law, Licensee waives, and shall procure that any Service Recipients and Authorised Users waive, any moral and similar rights they may have in such Feedback. Licensee acknowledges that Accurx may use Feedback to develop Improvements.
Without prejudice to the generality of the foregoing and to the provisions of clause 5.5 and 5.6 and notwithstanding any rights or remedies of Accurx, any and all Intellectual Property Rights in and to any Improvements to the Platform however arising shall immediately vest in and be owned by Accurx without compensation or other obligation to Service Recipients or Authorised Users. Licensee shall procure Service Recipients' and Authorised Users' adherence to this clause 11.4.
To give effect to clause 11.4, Licensee shall, and shall procure that any other Service Recipients and all Authorised Users shall, assign to Accurx all existing and future Intellectual Property Rights in the Improvements and all materials embodying these rights to the fullest extent permitted by law. Insofar as they do not vest automatically by operation of law or under this Agreement, Licensee holds legal title in these rights and Improvements on trust for Accurx.
Licensee undertakes to execute, and to procure that Service Recipients and Authorised Users execute, all documents, make all applications, give all assistance and do all acts and things, at the expense of Accurx and at any time either during or after the Agreement, as may, in the opinion of Accurx be necessary or desirable to vest the Improvements in the name of Accurx.
Accurx shall defend Licensee against any third-party claims that the use of the Platform in accordance with this Agreement infringes any third-party Intellectual Property Right and subject to clauses 11.8 and 11.9 shall indemnify Licensee for and against any amounts awarded against Licensee in judgment or settlement of such claims, provided that:
Accurx is given prompt notice of such claim and sole authority to defend or settle the claim;
Licensee provides reasonable co-operation to Accurx in the defence and settlement of such claim, at Accurx’s expense;
neither Licensee nor any other Service Recipient makes any admission of liability or fault itself or on behalf of Accurx.
In the defence or settlement of any claim pursuant to clause 11.7 above, Accurx may at its sole option and expense either:
procure for Licensee the right to continue using the Platform in the manner contemplated by this Agreement;
replace or modify the Platform as applicable so that it becomes non-infringing; or
terminate this Agreement forthwith by notice without liability to Licensee.
Accurx shall not in any circumstances have any liability (including in respect of the indemnity provided under clause 11.7) if the alleged infringement is based on:
modification of the Platform by anyone other than Accurx or Improvements created independently by Licensee, Service Recipients or Authorised Users without input or written consent from Accurx;
Service Recipients’ and/or any Authorised User’s use of the Platform otherwise than in accordance with this Agreement and/or the AUP, or in a manner contrary to the instructions given to Licensee by Accurx; or
Service Recipient's or Authorised User’s use of the Platform after notice of the alleged or actual infringement from Accurx or any appropriate authority; or
use or combination of the Platform with any other software or hardware, in circumstances where, but for such combination, no infringement would have occurred; or
failure to meet the Minimum Specifications.
Subject to clause 11.9, Licensee shall defend Accurx against all or any costs, claims, damages or expenses incurred by Accurx in respect of any third-party claims relating to Licensee’s or any other Service Recipient's or any Authorised User’s use of the Platform otherwise than in accordance with this Agreement and/or the AUP, provided that Licensee is given prompt notice of such claim.
This Agreement shall commence as of the Effective Date and shall continue for the Initial Term, unless terminated earlier in accordance with this Agreement.
On expiry of the Initial Term, this Agreement shall automatically renew for successive periods equal to the longer of twelve (12) months or the length of the Initial Term (each, a “Renewal Term”), unless:
specified otherwise in the Order Form; or
either Party provides the other with written notice to terminate this Agreement at least sixty (60) days prior to the expiry of the Initial Term, or at least thirty (30) days’ prior to the expiry of the Initial Term where the Initial Term is a period of less than twelve (12) months; or
either Party provides the other with written notice to terminate this Agreement for any reason during any Renewal Term, such notice to be given at least thirty (30) days prior to the expiry of the relevant Renewal Term.
this Agreement is terminated earlier in accordance with its terms.
The addition of new Service Recipients or Products shall not increase the Term, unless confirmed by Accurx otherwise.
Without affecting any other right or remedy available to Accurx, it may terminate this Agreement with immediate effect by giving written notice to Licensee if Accurx in its sole discretion determines it necessary where:
there is an error in an Order Form which has been submitted by Licensee via the Site; or
Accurx has not received full payment of the Charges within thirty (30) days of the relevant suspension taking effect under clause 9.5.
Without affecting any other right or remedy available to Accurx, if it knows or has reasonable grounds to suspect that Licensee is acting in breach of its obligations under this Agreement (excluding any failure to pay the Charges), Accurx may, on ten (10) Business Days’ written notice to Licensee, suspend access to the Platform until such breach is remedied or until Accurx is satisfied (acting reasonably) that its suspicions are unfounded.
Without affecting any other right or remedy available to the Parties, either Party may terminate this Agreement with immediate effect by giving written notice to the other Party if:
the other Party commits a material breach of any terms of this Agreement, which breach is irremediable or fails to remedy that breach within thirty (30) days after being notified in writing to do so (in relation to breaches by Service Recipients and Authorised Users, Accurx shall determine whether such breach is remediable in its sole discretion) ; or
the other Party suspends, ceases, or threatens to suspend or cease carrying on its business or a substantial part thereof, or suffers an Insolvency Event; or
a Commissioning Organisation enters into an agreement with Accurx for the same Product and Service Recipients.
If Accurx validly terminates the Agreement under clause 12.6, all Charges payable for the remainder of the Term become immediately due and payable and no refund is due.
If Licensee validly terminates the Agreement under clauses 12.6.1 and 12.6.3, Accurx shall refund any pre-paid unused Charges for the remainder of the Term.
On termination of this Agreement for any reason:
all licences granted under this Agreement shall immediately terminate;
each Party shall return and make no further use of any Confidential Information, equipment, property and other items (and all copies of them) belonging to the other Party;
any rights, remedies, obligations or liabilities of the Parties that have accrued up to the date of termination, including the right to claim damages in respect of any breach of the Agreement which existed at or before the date of termination shall not be affected or prejudiced; and
Accurx shall arrange for the return of any data in accordance with the DPA.
This clause 13 sets out the entire financial liability of Accurx to Licensee arising under or in connection with this Agreement, in respect of any use made by Service Recipients, its Authorised Users or any other third-parties of the Platform; and in respect of any representation, statement or tortious act or omission (including negligence) arising under or in connection with this Agreement.
Nothing in this Agreement excludes either Party’s liability for death or personal injury caused by its negligence, fraud or fraudulent misrepresentation or for any liabilities that cannot be excluded under applicable law.
Subject to clause 13.2 neither party shall be liable for:
any consequential, indirect, special, incidental, punitive or exemplary damages, whether foreseeable or unforeseeable;
loss of profit, loss of business;
loss caused as a result of the Platform being unavailable as a result of planned downtime for the Platform as notified to Licensee;
loss caused as a result of the Platform being unavailable caused by a Force Majeure Event
any loss or damage caused by a Virus, distributed denial-of-service attack, or other technologically harmful material that may infect the Service Recipient's computer equipment, computer programmes, data or other proprietary material due to your use of the Platform unless caused by Accurx’s negligence;
any loss of data, use, goodwill, or other intangible losses;
any loss or damage arising from an inability to access or use the Platform;
Subject to clauses 13.2 and 13.3, Accurx's total aggregate liability in contract, tort (including negligence), or otherwise arising out of or relating to this Agreement shall be limited to the higher of:
the total Licence Fee paid or payable during the twelve (12) months immediately preceding the event or series of connected events giving rise to the claim; and
£250,000 (two hundred and fifty thousand pounds).
save that Accurx’s total aggregate liability for any claims arising out of or in connection with a breach of the DPA or Data Protection Legislation shall not exceed £1,000,000 (one million pounds) in aggregate for all losses incurred by any or all Service Recipients collectively, whether arising from a single event or series of related events (“Data Protection Liability Cap”). Notwithstanding anything to the contrary in the DPA or the Agreement, no indemnity given by Accurx shall apply to, or require reimbursement of, any administrative fines, penalties, sanctions or similar amounts imposed by a competent supervisory authority or other regulatory body under applicable Data Protection Legislation, except to the extent that such exclusion is prohibited or unenforceable as a matter of applicable law.
Accurx may assign the Agreement on notice to Licensee to an Affiliate or in connection with a Change of Control or sale of substantially all assets, provided the assignee assumes the assigning party's obligation.
Subject to clauses 14.3 and 14.4, Licensee shall not, without the prior written consent of Accurx, assign, transfer, charge, sub-contract, or deal in any other manner with all or any of its rights or obligations under this Agreement.
In the case of Licensee merging with a third party, Licensee shall give Accurx at least thirty (30) days' written notice of any such merger and such notice shall include:
the name, address and national code (for example ODS code) of the proposed merger party that will assume engagement of Licensee's Service Recipients and care of its Patients; and
the date upon which such merger shall be effective.
Should a merger occur that results in the merger party assuming engagement of Service Recipients and responsibility for Licensee's Patients, Accurx's consent to the merger shall be implied, provided notice has been served pursuant to clause 14.3 and that such merger does not materially and adversely affect the financial position of Accurx, and Licensee shall procure that the merger party agrees to meet all obligations of Licensee under this Agreement and execute a deed of variation of this Agreement to that effect.
“Confidential Information” means all confidential information (however recorded or preserved) disclosed by one Party or its employees, officers, representatives or advisers (together “Representatives”) to the other Party and the other Party’s Representatives whether before or after the Effective Date, including the terms of this Agreement; the business, affairs, licensees, clients, suppliers, plans, intentions, market opportunities, the operations, processes, product information, know-how, technical information or trade secrets of the disclosing Party.
Confidential Information of the disclosing Party shall not include information which:
is or becomes generally available to the public, other than as a result of a disclosure by the receiving Party or any of its Representatives;
has been rightfully received by the receiving Party from a third-party without confidentiality restrictions;
has been independently developed by the receiving Party without use of or reference to the disclosing Party's Confidential Information; or
the Parties agree in writing is not confidential or may be disclosed.
The Confidential Information of the disclosing Party will be kept confidential and will not be disclosed or divulged by the receiving Party to anyone except with the disclosing Party’s prior written permission, or as may be required by law or by the order or demand of a court or government agency or authority.
Notwithstanding the foregoing, the receiving Party may disclose the disclosing party’s Confidential Information to the receiving Party’s Representatives who need to review such Confidential Information, so long as they are bound by confidentiality obligations no less restrictive than those in this clause 15. The receiving Party shall be liable for any breach of these confidentiality obligations by their Representatives.
Upon expiration or earlier termination of this Agreement for any reason, the receiving Party will return to the disclosing Party or destroy (at the disclosing Party’s sole discretion) all Confidential Information of the disclosing Party and all copies thereof (except that Licensee may retain any Confidential Information needed to fulfil orders then pending as contemplated by this Agreement only until such orders are fulfilled and then must return or destroy, at Accurx’s sole discretion, all Confidential Information) and, upon the written request of the disclosing Party, an authorised officer of the receiving Party will certify in writing to the disclosing Party that the receiving Party has complied with this clause 15.5. In such event, the receiving Party will continue to be bound by this clause 15.
Notwithstanding the foregoing, Licensee permits Accurx to identify Licensee as a client. To this end, Licensee grants Accurx a perpetual, non-exclusive, royalty-free and non-transferable licence during the Term of the Agreement for Accurx to use Licensee’s logo, name and branding on the Site and in any marketing and publication materials.
The relationship between the Parties is that of independent contractors and nothing herein shall be construed to create a partnership, joint venture, or agency relationship between the Parties hereto nor authorise any Party to make or enter into any commitments for or on behalf of any other Party. Each Party confirms it is acting on its own behalf and not for the benefit of any other person.
Dispute: Licensee agrees that if they have any dispute with Accurx concerning this Agreement, they agree to contact Accurx first and attempt to resolve the issue informally. If the Parties are unable to resolve the dispute between themselves informally they both agree to attempt resolution by independent mediation. Should independent mediation not be successful, the Parties both agree to resolve the dispute through court action which will be subject to the exclusive jurisdiction of English courts.
Entire Agreement: This Agreement constitutes the entire Agreement between the Parties and supersedes and extinguishes all prior and contemporaneous agreements, negotiations, promises, assurances, warranties, understandings and representations between them, whether written or oral, relating to its subject matter. Each Party agrees that it shall have no claim for innocent or negligent misrepresentation or negligent misstatement based on any statement in this Agreement.
Amendment: These Terms and Conditions may be revised at any time by Accurx and any modifications shall become effective and binding as follows:
Non-material updates: these may be made by Accurx from time to time and shall become binding immediately after the change has been made. Non-material updates are changes that do not fundamentally alter a Party’s rights or obligations, such as correcting grammatical or clause numbering.
Material updates: Accurx shall notify Licensee (for example, by contacting the Key Contact) by email or by notification within the Platform of any material changes, together with a summary of those changes where reasonably practicable, and such changes shall become effective thirty (30) days after Accurx’s notification unless Accurx has received a written objection from Licensee in accordance with clause 17.3.3. While Accurx will use commercially reasonable endeavours to notify any Service Recipients and Authorised Users of these updates, Licensee is responsible for ensuring they are aware of these updates. Material updates are changes that may fundamentally alter a Party’s rights or obligations, such as conditions of access to the Platform or changes to liabilities or indemnities.
If Licensee does not agree with any material changes notified to it under clause 17.3.2, it shall notify Accurx in writing, setting out the reasons why such modification is not accepted, within ten (10) Business Days of Accurx’s notification. If the Parties cannot resolve Licensee’s objection, the Agreement shall continue to be governed by the Terms and Conditions in force immediately before the change until the end of the then-current Term, after which the most recent Terms and Conditions published on the Site (at https://www.accurx.com/terms-and-conditions) will apply.
If Licensee objects in accordance with clause 17.3.3 and Accurx can no longer reasonably provide access to the Platform under the Terms and Conditions prior to modification (for example, where modifications are required by a change in applicable law (including Data Protection Legislation), are necessary to ensure the security or integrity of the Platform, or result from general product changes), the Agreement will terminate immediately upon Accurx giving written notice to Licensee. In such event, Accurx will (if relevant) promptly refund any prepaid but unused fees covering use of the Platform after termination.
The most recent Terms and Conditions will always be published on the Site (at https://www.accurx.com/terms-and-conditions) and Accurx may provide a summary of any changes made upon written request from Licensee. By continuing to access or use the Platform, Service Recipients agree to be bound by the most up to date Terms and Conditions, provided no objection has been received in accordance with clause 17.3.3.
Waiver: A waiver by any Party of any of its rights hereunder shall not be binding unless in writing signed by an authorised representative of the Party expressly waiving such rights. The non-enforcement or waiver of any provision on any occasion shall not constitute a waiver of such provision on any other occasions unless expressly so agreed in writing.
Severability: If any provision or part-provision of this Agreement becomes or is held invalid, illegal, or unenforceable, it shall be deemed modified or deleted to the minimum extent necessary but that shall not affect the validity and enforceability of the rest of this Agreement.
Rights and Remedies: Except as expressly provided in this Agreement, the rights and remedies provided under this Agreement are in addition to, and not exclusive of, any rights or remedies provided by law.
Force Majeure: Neither Party shall in any circumstances be in breach of this Agreement nor liable for delay in performing, or failure to perform, any of its obligations under this Agreement if such delay or failure results from events, beyond its reasonable control, including, without limitation, strikes, acts of God, war, terrorism, riot, denial of service attacks, epidemic, pandemic or compliance with any law or governmental order (“Force Majeure Event”). In such circumstances the affected Party shall be entitled to a reasonable extension of the time for performing such obligations, provided that if the period of delay or non-performance continues for three (3) months, the Party not affected may terminate this Agreement by giving thirty (30) days' written notice to the other Party.
Third-Party Rights: No one other than a Party to this Agreement, their successors and permitted assignees, shall have any right to enforce any of its terms, whether pursuant to the Contracts (Rights of Third Parties) Act 1999 or otherwise.
Notices: Any notice given to a Party under or in connection with this Agreement shall be in writing and delivered, and shall be deemed to have been received as follows:
Party | Addressee | Address | Email address |
|---|---|---|---|
Accurx: | Accurx | 7 Curtain Road, London, England EC2A 3LT | |
Licensee: | Key Contact | Licensee address as set out in the Order Form | Key Contact’s email address as set out in the Order Form |
Method | Deemed receipt |
|---|---|
By hand | At the time the notice is left at the Receiving Party’s address identified above |
By pre-paid first-class post or other next working day delivery service | At 9.00 am on the second Business Day after posting |
By email | At 9.00 am on the next Business Day after transmission |
Licensee acknowledges and agrees that any notification requirements under this Agreement shall be satisfied by Accurx notifying Licensee on behalf of any Service Recipients.
Notwithstanding clause 17.9.1, the notice requirements in this clause 17.9 shall not apply to the service of legal proceedings.
Governing Law and Jurisdiction: This Agreement shall be governed by and construed in accordance with the laws of England and Wales and the Parties agree that the English and Welsh courts shall have exclusive jurisdiction.
The following definitions and rules of interpretation shall apply in this Agreement.
“Acceptable Use Policy” or “AUP” means the written policy made available to Authorised Users and Authorised Free Users when using the Platform and set out at http://www.accurx.com/acceptable-use-policy (as may be updated from time to time during the Term by Accurx) which sets out the authorised uses of the Platform and its associated services.
“Account” means the user account that each Authorised User and Authorised Free User has to create in order to gain access to the Platform.
“Accurx” means Accurx Limited a company registered in England with company number 10184077 whose registered office is at 7 Curtain Road, London, England EC2A 3LT.
“Accurx Lite” means the free to use version of Accurx that has limited functionality and limits on its usage as set out https://support.accurx.com/en/articles/4453468-accurx-lite-vs-accurx-plus-what-are-the-differences (as may be updated from time to time during the Term by Accurx) or as otherwise notified to Service Recipients and Authorised Users by Accurx using any reasonable means, and is included in the definition of Product setout herein.
“Accurx Mobile Directory” means the hospital directory of contacts which is available through Accurx Mobile and which Authorised Users can access and update with mobile numbers and email addresses of contacts within a hospital, and is included in the definition of Product set out herein.
“Accurx Mobile” means the mobile phone application (available on the Apple and Android app stores) that allows healthcare professionals to collaborate and communicate securely with each other and Patients, and is included in the definition of Product set out herein.
“Accurx Navigator” means the product feature designed to educate and signpost Patients to additional information or services about their health issue during their journey of contacting their GP through the Platform, and is included in the definition of Product set out herein.
“Accurx Scribe” means the AI enabled ambient scribe solution powered by Tandem that is available within the Platform, and is included in the definition of Product set out herein.
“Administrator Privileges” means the elevated access rights granted to an Authorised User within a Workspace, which include the ability to: (i) add or remove Authorised Users from that Workspace; (ii) grant or revoke Administrator Privileges for other Authorised Users within that Workspace; and (iii) where applicable, accept material updates to the Terms and Conditions and DPA on behalf of the organisation to which that Workspace relates.
"Affiliate" means any entity that directly or indirectly Controls, is Controlled by, or is under common Control with a party to the Agreement, where “Control” has the meaning given in section 1124 of the Corporation Tax Act 2010.
“Agreement” means the Order Form (where applicable) and the Terms and Conditions (and any and all additional annexes or schedules thereto).
“AI Features” means all features and functionality that use Artificial Intelligence ("AI") and machine learning technologies within the Platform.
“AI Services Schedule” means the schedule governing the use of AI Features set out in Schedule 5.
“Analytical Data” means any data which is derived from the Patients’, Service Recipients' and Authorised Users’ use of the Platform or the Processing of Service Recipient Data, and shall include: (i) any data which is processed and stored as mathematical constructs; and (ii) statistical or aggregated data, but shall exclude any Personal Data.
“Ancillary Fees" means any costs or fees set out in the Order Form relating to additional work items (such as further implementation or training costs).
“Authorised Use” means, as the case may be: (i) communication with and the provision of direct care services to Patients registered with Service Recipients in the Territory; or (ii) communication between healthcare professionals about the provision of direct care services to Patients in the Territory.
“Authorised Free Users” means those healthcare professionals who are authorised to use the Platform for free in accordance with these Terms and Conditions (each a "HCP") provided that: (i) the HCP is not otherwise authorised as an Authorised User by a Service Recipient pursuant to these Terms and Conditions; and/or (ii) there is no other agreement in place between Accurx and the organisation that engages the HCP which governs the HCP's use or access to the Platform.
“Authorised Users” means those employees, agents, licensees, or contractors of Service Recipients with appropriate qualifications and expertise to provide the relevant health and care services who are authorised by Licensee to use the Platform, including any FTEs.
“Business Day” means a day other than a Saturday, Sunday or public holiday in England when banks in London are open for business.
“Caldicott Principles” means the principles that apply to the use of confidential information within health and social care organisations and the sharing of such information with other organisations which are available at https://www.gov.uk/government/publications/the-caldicott-principles, as may be updated from time to time during the Term.
“Case Study” means any case study or similar report setting out the benefits and findings of a pilot or other project undertaken by Licensee and Accurx which may be published by Accurx (for example as an article on the Site), as defined or set out in the Order Form, or as otherwise confirmed to Licensee by Accurx using reasonable means.
“Change of Control” means any event in which a person or group of persons acting in concert gains direct or indirect control of a company, where “Control” has the meaning given in section 1124 of the Corporation Tax Act 2010.
“Charges” means the Licence Fees, SMS Costs, Ancillary Fees and any other fees or charges as confirmed in the Order Form.
“Commissioning Contract” has the meaning set out in clause 2.1.
“Commissioning Organisation” means any organisation (such as an Integrated Care Board or PCN) that subsequently enters into a separate agreement with Accurx for the same Products and Service Recipients and/or Patients during periods that overlap with the Licensee’s Agreement with Accurx.
“Confidential Information” has the meaning set out in clause 15.
“Data Protection Legislation” means (i) UK GDPR as defined in section 3(10) (as supplemented by section 205(4)) of the UK's Data Protection Act 2018; (ii) the Data Protection Act 2018 to the extent that it relates to the Processing of Personal Data and privacy; and (iii) any other law in force from time to time with regards to the Processing of Personal Data and privacy, which may apply to either Party in respect of its activities under this Agreement.
“Data Subjects, Personal Data and Processing” shall have the meaning as defined in the Data Protection Legislation.
“Documentation” means any of the following as distributed or otherwise provided by Accurx in relation to the Platform or its use: (i) printed or online instructions, manuals, and diagrams; and (ii) e-learning materials or webinars.
“Data Processing Agreement” or “DPA” means the Data Processing Agreement set out at https://www.accurx.com/data-processing-agreement, as may be updated from time to time during the Term by Accurx.
“Data Protection Liability Cap” has the meaning set out in clause 13.4.
“Disclaimers” means the General Platform Disclaimer and the General AI Disclaimer.
“Effective Date” means the date an Order Form is submitted and Licensee accepts these Terms and Conditions, or the date on which a Licensee otherwise agrees to these Terms and Conditions.
“Feedback” has the meaning set out in clause 11.3.
“Force Majeure Event” has the meaning set out in clause 17.7.
"Free Services" means where access to the Platform has been granted by Accurx to any Service Recipient (and its Authorised Users) on the basis of beta access, a free trial or pilot period (which includes but is not limited to Accurx Lite), and includes an Authorised Free User’s general access to the Platform.
“FTEs” means all full time equivalent individuals employed by Service Recipients and is the proxy used to determine the Licence Fee payable by certain organisations as confirmed in the Order Form.
“General AI Disclaimer” means the disclaimer set out in Annex 1 of Schedule 5 that applies to all AI Features used by Service Recipients and Authorised Users.
“General Platform Disclaimer” means the disclaimer set out in Schedule 4 that applies to any and all use of the Platform by Service Recipients and Authorised Users.
“Improvements" means any modifications, adaptations, developments, or any derivative works of or to the Products or the operation of the Platform, including any enhancements, features, functionality, configurations, templates, documentation, or other materials that are developed as part of, or result from, any agreed improvements to the Platform under this Agreement including but not limited to any new content such as information relating to proposed questions for Accurx's questionnaire product or a message or an Accurx Scribe consultation/transcription summary template for the Products, whether derived by Accurx from Analytical Data, made collaboratively between Service Recipients, Authorised Users and Accurx, or independently by Service Recipients or Authorised User (including where such Improvements are created without Accurx's prior written consent).
“Initial Term” means the period of 12 months starting on the Switch-on Date unless specified otherwise in the Order Form.
“Insolvency Event” means, with respect to a Party, (i) entering into a composition or arrangement with its creditors other than for the sole purpose of a solvent reconstruction; (ii) an inability to pay its debts as they become due; (iii) a person becoming entitled to appoint or appointing a receiver or an administrative receiver over that Party’s assets; (iv) a creditor or encumbrancer attaching or taking possession of the whole or any part of that Party's assets which is not discharged within 14 days; or (v) the occurrence of any event, or the taking of any proceedings, in any jurisdiction that has an effect equivalent or similar to any of the events mentioned in (i) to (iv) above.
“Intellectual Property Rights” means patents, rights to inventions, copyright and neighbouring and related rights, trade marks, goodwill and all other intellectual property rights, in each case whether registered or unregistered and including all applications and rights to apply for and be granted, renewals or extensions of, and rights to claim priority from, such rights and all similar or equivalent rights or forms of protection which subsist or will subsist now or in the future in any part of the world.
“Key Contact” means either: (i) the individual nominated by Licensee as the main contact to receive notices and updates relating to this Agreement during the Term (including notices under clause 17.3), as identified in the Order Form; (ii) an Authorised User with Administrator Privileges in a Workspace; or (iii) other appropriate individual as identified by Accurx acting reasonably. In the context of an Authorised Free User, the Key Contact shall be the individual Authorised Free User.
“Licence Fee” means the fee set out in the Order Form or the sum of £NIL if the Products and access to the Platform are not being paid for and are being used or accessed by an Authorised Free User.
“Licensee” means, as applicable: (i) the organisation set out in the Order Form; or (ii) the Authorised Free Users.
“Medical Device” means any Product or functionality intended by Accurx to be used for a specific medical purpose and which constitutes a medical device as defined under and regulated by the Medical Device Legislation and any guidance issued by the Medicines and Healthcare products Regulatory Agency (MHRA) from time to time.
“Medical Device Information” means the document setting out the intended purpose, contraindication, warnings, precautions and incident reporting obligations applicable to each Medical Device, as set out in the Product Specific Terms.
“Medical Device Legislation” means (i) all applicable law, statutes, directives, regulations and industry codes of conduct relating to Medical Devices which are in force from time to time, including without limitation, the UK Medical Device Regulations 2002, and the Medicines and Medical Devices Act 2021, and (ii) any and all amendments or modifications made from time to time to the items referenced in (i).
“Minimum Specifications” means the minimum requirements that Service Recipients and Authorised Users must ensure their devices and computers have in order for them to be able to access the Platform. The Minimum Specifications are accessible at the following webpages on the Site and may be updated from time to time during the Term by Accurx: for desktop computer requirements, for web browser requirements and for internet speed/connectivity requirements.
“NHS Code” means the NHS Code of Practice on confidential information which is available at https://www.gov.uk/government/publications/confidentiality-nhs-code-of-practice, as may be updated from time to time during the Term.
“NHS Constitution” means the NHS Constitution on the principles and values of the NHS in England which is available at https://www.gov.uk/government/publications/the-nhs-constitution-for-england, as may be updated from time to time during the Term.
“Order Form” means the Accurx-approved form or online subscription process through which Licensee requests procurement of and access to the Platform.
“Party” means a party to this Agreement, being either Accurx or Licensee and “Parties” means both of them.
“Patient” means an individual who receives or requires direct care services from Service Recipients or an Authorised Free User, including where that individual is contacted through or as part of the Platform, is the subject of a consultation, or whose Patient Data is processed or accessed through the Platform in connection with their care.
“Patient Data” means information about Patients (which may include Personal Data) accessed by Service Recipients or Authorised Free Users using third-party services such as the NHS Spine (for example, PDS) or Service Recipients' clinical record systems, or provided by Patients when responding to or contacting Service Recipients and Authorised Users via the Platform.
“Patient Initiated Forms” means the set of online consultation tools which help Patients get in contact with their healthcare provider (for example a GP practice) and support healthcare teams in managing inbound medical and administrative requests from patients, alongside other routes (for example, walk-in, phone), and is included in the definition of Product set out herein.
“Payment Terms” means the frequency at and payment method by which Licensee agrees to pay Accurx as set out and confirmed in the Order Form, or as otherwise confirmed to Licensee by Accurx using reasonable means.
Platform” means the cloud-based software which is owned, operated, and made available on a software-as-a-service basis by Accurx to Service Recipients and Authorised Users, which includes the Products, any Improvements, and any related software or ancillary products and services (such as user support).Recipients' clinical record systems, or provided by Patients when responding to or contacting Service Recipients and Authorised Users via the Platform.
“Product” means those products that Service Recipients and Authorised Users are authorised to use by Accurx for the Authorised Use, as listed in the Order Form or otherwise made available by Accurx to Service Recipients and Authorised Users, including any features and functionality defined as Products in these Terms and Conditions.
“Product Specific Terms” means the schedule applicable to a specific Product setting out the conditions of use, disclaimers, and other provisions that apply to the use of that Products by Service Recipients and Authorised Users.
“Privacy Notice” means Accurx’s privacy notice which is accessible at https://www.accurx.com/privacy-policy, as updated from time to time during the Term by Accurx.
“Renewal Term” means the period defined as such in clause 12.2.
“Service Recipients” means Licensee and any healthcare organisations, departments, workspaces, specialities, services and/or clinical systems (as the case may be) listed in the Order Form, or as agreed or confirmed by Licensee if there is no Order Form, who are authorised to use the Platform for the Authorised Use.
“Service Recipient Data” means the data uploaded, submitted or collected via the Platform including without limitation all anonymised business data, but excluding any Analytical Data and Patient Data.
“Service Recipient Personal Data” means Personal Data contained in the Service Recipient Data which is limited to the employees’ names and email addresses.
“Site” means https://www.accurx.com/ and all relevant subdomains or such other URL as updated from time to time by Accurx.
“SLA” means the service level agreement setting out the agreed service and support levels for the Platform which is accessible at http://www.accurx.com/accurx-service-level-agreement-sla, as updated from time to time during the Term by Accurx.
“Smart Triage Questions” or “STQs” means the AI Feature available as a bolt-on to Patient Initiated Forms that automatically generates follow-up questions based on information submitted by a Patient, designed to assist Service Recipients and Authorised Users in gathering additional clinical information to support the review of online Patient submissions, and is included in the definition of Product set out herein.
“SMS Costs” means any SMS Fragments sent by Service Recipients using the Platform, chargeable at the cost set out in the Order Form.
“SMS Fragment” means the component of an SMS message with each fragment being 160 characters.
“Sub-processor” means any natural or legal person, public authority, agency or other body which possesses Personal Data on behalf of a data controller or a data processor.
“Switch-on Date” means the date that Licensee and any other Service Recipients and Authorised Users will be able to access and use the Platform. The Switch-on Date is set out in the Order Form. In the event there is no Order Form, the Switch-on Date is the Effective Date or the date as otherwise notified to the Service Recipients and Authorised Users by Accurx using any reasonable means. In both scenarios, the Switch-on Date is the date from which any Licence Fee and SMS Costs will be charged by Accurx to Licensee, except in the context of Free Services.
“Term” means the Initial Term and any Renewal Terms, unless confirmed otherwise in the Order Form.
“Terms and Conditions” means these terms and conditions set out in clause 1 to 17 (inclusive) and any and all additional schedules which are accessible at https://www.accurx.com/terms-and-conditions, as may be updated from time to time by Accurx in accordance with clause 17.3.
“Territory” means the territory or territories in which use of the Platform is authorised, as identified in the Order Form or otherwise confirmed by or to Accurx in the creation of the Account.
“Trial Period” means the duration of the Free Services as set out in the Order Form or as otherwise notified to Service Recipients and Authorised Users by Accurx using any reasonable means, or in any other case, the period of thirty (30) days beginning on the commencement of the Free Services.
“Trust Centre” means the online resource centre maintained by Accurx which is available at https://trust.assuric.com/accurx/public, as may be updated from time to time during the Term by Accurx, and contains the latest security, clinical safety, Sub-processor and compliance information relating to the Platform.
“Virus” means any thing or device (including any software, code, file or programme) which may: prevent, impair or otherwise adversely affect the operation of any computer software, hardware or network, any telecommunications service, equipment or network or any other service or device; prevent, impair or otherwise adversely affect access to or the operation of any programme or data, including the reliability of any programme or data (whether by re-arranging, altering or erasing the programme or data in whole or part or otherwise); or adversely affect the user experience, including worms, trojan horses, viruses and other similar things or devices.
“Workspace” means a defined group of Authorised Users within the Platform representing a team, department, service or organisation (such as a GP practice), through which Authorised Users with access to that Workspace are able to collaborate, deliver care to and communicate with Patients through a shared inbox and other functionality made available within the Platform by Accurx from time to time.
In this Agreement:
clause, schedule, paragraph headings and any paragraphs starting with “In short” shall not affect the interpretation of this Agreement;
unless the context otherwise requires, words in the singular shall include the plural and words in the plural shall include the singular;
a reference to writing or written includes e-mail;
references to clauses and schedules are to the clauses and schedules of this Agreement; references to paragraphs are to paragraphs of the relevant schedule to this Agreement; and
any words following the terms including, include, in particular for example or any similar expression shall be construed as illustrative and shall not limit the sense of the words, description, definition, phrase or term preceding those terms.
The following provisions shall apply to Licensee's and any Service Recipients' access to and use of the Platform where a Commissioning Organisation has entered into a Commissioning Contract with Accurx.
These Terms and Conditions (as modified by this Schedule 2) will act as an end user licence agreement and, in addition to Licensee’s compliance with this Agreement, Licensee’s right to access and use the Platform is subject to the provisions of any written agreement with the Commissioning Organisation.
Licensee’s right to terminate or cancel access to the Platform is solely as described in Commissioning Organisation’s agreement with Accurx, or as otherwise agreed in writing with Accurx.
The following clauses of the Terms and Conditions shall not apply:
3 (Order Form);
7 (Accurx’s Obligations);
9 excluding 9.5.1, 9.6 and 9.7 (Payment);
12 excluding 12.6 and 12.9 (Term and Termination); and
14 (Assignment).
For the avoidance of doubt, Licensee’s indemnity at clause 8.6 and compliance with the Disclaimers, Product Specific Terms and the Medical Device Information, Accurx’s right to suspend in the event of non-payment at clause 9.5, and the Data Protection Liability Cap shall all continue to apply, save that the figure of £1,000,000 (one million pounds) shall be deleted and replaced with £10,000,000 (ten million pounds) in the Data Protection Liability Cap where the Commissioning Organisation is an Integrated Care Board (ICB). For the purposes of any cap on liability, the amount paid or payable by Commissioning Organisation to Accurx for Licensee’s use of the Platform is treated as the amount paid or payable by Licensee to Accurx.
If Commissioning Organisation ceases at any time to have an agreement with Accurx, Licensee’s continued use of the Platform may be conditioned upon Licensee executing an Order Form directly with Accurx for such use in accordance with clause 3. If Commissioning Organisation has failed to pay any Charges under its agreement with Accurx, Licensee may be required to pay the outstanding Charges in accordance with clause 9.6.
Commissioning Organisations are not authorised to modify the Agreement or make any promises or commitments on Accurx’s behalf, and Accurx is not bound by any obligations to Licensee other than as set forth in this Agreement.
The provisions of this Schedule 3 shall only apply to the Free Services and any use of the Platform by an Authorised Free User ("Trial User"). In the event of any conflict or inconsistency between the other provisions of the Terms and Conditions as they relate to the Free Services and the provisions of this Schedule 3, the provisions of this Schedule 3 shall prevail to the extent of the conflict or inconsistency. Unless stated otherwise in the Order Form, the following clauses of the Terms and Conditions shall not apply to Free Services:
Clause 9 (Payment);
Clauses 12.1 and 12.2 (Term);
Clause 13 (Liability) excluding clauses 13.2 and 13.3 which shall apply;
Clauses 14.3 and 14.4 (Assignment),
for the avoidance of doubt, the Order Form may also exclude additional clauses from applying to a Free Services and access to the Platform as part of Free Services remains subject to the Disclaimers, Product Specific Terms and the Medical Device Information.
If Licensee already has an agreement in place with Accurx for access to the Platform and wishes to test a new feature which is available as part of Free Services, Accurx may provide Licensee with access to that specific feature, functionality, tool, service or Product (“Trial Feature”), and the provisions of this Schedule 3 shall apply solely in respect of the Trial Feature, with all other aspects of the Agreement continuing unchanged for the remainder of the Platform. In such event:
the Trial Feature will be considered added to the Agreement for the Trial Period and any use, access, rights, obligations and liability for the Trial Feature will be governed by this Schedule 3; and
upon expiry or earlier termination of the Trial Period for this Trial Feature, Licensee and Accurx shall agree in writing whether the Trial Feature will be added to the Agreement in accordance with paragraph 5, or whether access to the Trial Feature will end.
Each Service Recipient and Authorised Free User acknowledges that access to the Platform as part of Free Services may be limited as follows:
Accurx Lite: use of the Platform is subject to the usage limitations set out and accessible at https://support.accurx.com/en/articles/4453468-accurx-lite-vs-accurx-plus-what-are-the-differences (which may be updated from time to time during the Term by Accurx);
Accurx Scribe: use of Accurx Scribe is subject to usage limitations according to the relevant access for Service Recipients set out and accessible https://support.accurx.com/en/articles/4453468-accurx-lite-vs-accurx-plus-what-are-the-differences (which may be updated from time to time during the Term by Accurx);
All other usage: use of the Platform may be subject to limitations (for example, on the number of messages that can be sent) as specified in the Order Form or as otherwise notified to Service Recipients and Authorised Users by Accurx using any reasonable means in writing by Accurx.
Duration: During the Trial Period, Accurx will make the Platform available to Trial User on a trial basis until the earlier of:
expiry of the Trial Period (in the context of an Authorised Free User, the Trial Period shall expire when the Authorised Free User no longer uses or has access to the Platform);
the date on which Licence Fee becomes payable by Trial User following execution of an Order Form agreed with Accurx in accordance with paragraph 5 or clause 3 of the Terms and Conditions (as applicable); and
termination of the Trial Period by Accurx or Trial User at any time before the expiry of the Trial Period for whatever reason by giving notice to the other in writing.
Paid contract: Where the Order Form specifies that the Free Services will convert automatically to paid access to the Platform, upon expiry of the Trial Period the following shall apply:
Trial User shall be referred to as and shall become Licensee and be subject to these Terms and Conditions accordingly;
The Charges set out in the Order Form (or as otherwise notified to Trial User in writing by Accurx before access to the Free Services or the expiry of such access), shall become payable in accordance with clause 9;
Any Service Recipients listed in the Order Form will continue to be covered by Licensee's paid access, unless confirmed otherwise by Licensee or Accurx to the other before the expiry of the Trial Period;
The Initial Term will commence on expiry of the Trial Period and continue for the Term as set out at clause 12;
Accurx may issue a new Order Form in accordance with clause 3 to confirm the details of any paid contract, including the Products which can be accessed, the Charges, the Payment Terms, and the identities of any other Service Recipients.
Disclaimer: During the Trial Period, the Platform is made available to Trial User "as is", and any use by a Trial User of the Platform during the Trial Period will be at Trial User's sole risk. Accurx makes no warranties relating to the Platform throughout the Trial Period and expressly disclaims all warranties, express or implied, including without limitation those of merchantability, fitness for a particular purpose, or that Trial User's use of the Platform during the Trial Period will be uninterrupted, timely, secure or free from error and Accurx’s commitments in the SLA shall not apply to a Free Services. The foregoing provisions of this paragraph 6 shall be enforceable to the maximum extent permitted by applicable law.
Limitation of Liability: Subject to paragraph 1(c) of this Schedule, clause 13 shall not apply to Free Services and Accurx's total liability (including in relation to any breaches of the DPA or Data Protection Legislation) to a Trial User for any loss or damage relating to the Trial Period shall be £1,000 (one thousand pounds).
The following disclaimer is applicable to any and all use of the Platform by Service Recipients and Authorised Users.
The Platform is designed to support and facilitate communication between healthcare professionals and between healthcare professionals and Patients. It is not intended to replace clinical judgement, expertise or decision-making, and nothing in the Platform should be construed as constituting medical advice, diagnosis or treatment recommendations. Accordingly, Service Recipients and Authorised Users are solely responsible for:
all clinical assessments, responsibility, decisions and actions taken in connection with their use of the Platform, including any decisions made in reliance on the Content;
completing and maintaining all required clinical safety assessments in connection with their use of the Platform, including without limitation any assessments required under DCB0160 or any successor or equivalent standard. Accurx maintains DCB0129 documentation which is available via the Trust Centre, or upon request, and may be used by Service Recipients to complete DCB0160;
ensuring that their organisation remains fully registered with the Data Protection and Security Toolkit (“DSPT”), complies with the DSPT (including in relation to notifying NHS England about any data security and protection breaches or incidents), and maintains a current status of at least ‘standards met’ or (where applicable) of ‘approaching standards’.
completing and maintaining all required data protection and privacy assessments in connection with their use of the Platform, including without limitation Data Protection Impact Assessments (“DPIAs”) where required under applicable Data Protection Legislation. Accurx maintains guidance for completion of DPIAs for the relevant Products which are available via the Trust Centre, or upon request, and may be used by Service Recipients to inform or support their own DPIAs; and
ensuring their use of the Platform complies with all applicable laws, regulations, professional standards and guidance, including those of any relevant regulatory or professional body (such as NHS England or the ICO).
Accurx shall have no responsibility when Service Recipients and/or Authorised Users communicate with and/or undertake consultations with Patients using the Platform and accepts no liability for any clinical decisions or actions taken by Service Recipients or Authorised Users in connection with their use of the Platform, or for any failure by Service Recipients or Authorised Users to adhere to paragraph 1.
The following definitions shall apply in this Schedule:
“AI Input” means any data, content or instructions submitted by Service Recipients or Authorised Users to an AI Feature when using the Platform, or by Accurx on behalf of Service Recipients and Authorised Users through its provision of the Platform.
“AI Output” means any content, response, transcription, summary, or other output generated by an AI Feature based on an AI Input.
“General AI Disclaimer” means the disclaimer set out in this Schedule 5 which applies to all AI Features that are used by Service Recipients and Authorised Users.
The provisions of this Schedule shall apply where the Platform and Products include or make available AI Features for use by Service Recipients and Authorised Users.
This Schedule forms part of the Agreement. In any conflict or inconsistency between this Schedule and the main body of the Terms and Conditions, the provisions of this Schedule shall prevail to resolve such conflict in respect of any use of AI Features, except that the DPA shall prevail in respect of any rights, obligations or liability in relation to the Processing of Personal Data.
Capitalised terms not defined within this Schedule shall have the meanings in the Terms and Conditions.
Licensee and Service Recipients may use AI Features solely as part of the Authorised Use of the Platform and in accordance with the Agreement and this Schedule.
Licensee is responsible for all AI Inputs submitted by Service Recipients and Authorised Users to AI Features and shall ensure that it has all necessary rights, permissions and lawful bases to submit those AI Inputs.
Licensee shall not submit, and shall procure that Service Recipients and Authorised Users do not submit, to any AI Feature any data or materials that are not permitted to be submitted to the Platform under the Agreement, including any data submitted in breach of the AUP, applicable law or the DPA.
Licensee shall ensure that its privacy notices accurately describe the Processing of Personal Data through AI Features, including where that processing involves third-party AI providers, and that Data Subjects have been provided with appropriate transparency information before their data is submitted to any AI Feature. Licensee shall procure that Service Recipients comply with this obligation in respect of their own Data Subjects.
Licensee shall not use, and shall procure that Service Recipients and Authorised Users do not use, AI Features or AI Outputs to:
develop, train, fine-tune, benchmark or improve any product or service that competes with the Platform;
reverse engineer, extract or attempt to discover the underlying models, prompts, systems, algorithms, source code or methods used by Accurx or its AI providers;
generate unlawful, harmful, discriminatory, deceptive or malicious content;
circumvent usage limits, security controls or technical restrictions; or
make clinical decisions without appropriate human review, where such use could have clinical, legal, regulatory or patient safety consequences.
Accurx may process AI Inputs and AI Outputs to:
provide, operate, support and maintain the AI Features;
troubleshoot, debug, monitor and improve the performance, reliability and security of the AI Features; and
create and use Analytical Data in accordance with and subject to clause 6 of the Terms and Conditions.
Accurx may update, replace or modify AI Features from time to time, provided that any such update shall not materially reduce the overall functionality of the Platform during the applicable Term.
Where an AI Feature constitutes a Medical Device, Accurx maintains post-market surveillance in accordance with the Medical Device Legislation. As part of this obligation, Accurx may process limited, sampled extracts of data generated through use of Medical Device AI Features for clinical safety monitoring purposes, in accordance with the Privacy Notice.
Accurx will use reasonable endeavours to investigate and address performance issues with AI Features that are Medical Devices which are reported in accordance with the relevant Medical Device Information. Nothing in this Schedule or in the Product Specific Terms limits Accurx’s obligations as a medical device manufacturer under the Medical Device Legislation, including obligations relating to device performance, incident reporting and corrective action.
Licensee shall ensure that Service Recipients and Authorised Users comply with the Medical Device Information applicable to each AI Feature that is a Medical Device before use. The Medical Device Information for each relevant AI Feature is set out in the Product Specific Terms.
Accurx does not use Service Recipient Personal Data or Patient Data, or permit others to use Service Recipient Personal Data or Patient Data, to train, fine-tune, or improve the general purpose artificial intelligence and machine learning models used to provide AI Features. Service Recipients’ use of AI Features does not grant Accurx any right or licence to use Service Recipient Personal Data or Patient Data to train artificial intelligence or machine learning models.
Artificial intelligence and machine learning models can improve over time to better address specific use cases. Accurx may use data collected from Service Recipients’ and Authorised Users’ use of AI Features to improve the models Accurx uses when Service Recipients and Authorised Users:
voluntarily provide Feedback to Accurx such as by labelling AI Outputs generated by AI Features with a thumbs up or thumbs down; or
give Accurx their express permission.
Accurx processes any such Feedback in accordance with the Privacy Notice.
For the avoidance of doubt, nothing in this Schedule prevents Accurx from using general know-how, learnings, ideas or experience retained in the unaided memory of its personnel in connection with the provision of AI Features, provided that Accurx does not use or disclose Service Recipient Personal Data, Patient Data or Confidential Information in breach of the Agreement or the DPA.
Accurx may use third-party AI providers to provide elements of the AI Features. Where AI providers process Personal Data on behalf of Service Recipients, such Processing shall be governed by the DPA.
Licensee acknowledges that AI Features may depend on third-party AI providers and that availability, performance and functionality may be affected by those providers. Accurx shall not be in breach of the SLA to the extent any non-conformance is caused by a third-party AI provider, save where such non-conformance is directly caused by Accurx’s own act.
As between the Parties, Licensee and Service Recipients retain all rights in AI Inputs submitted to AI Features.
Subject to Licensee’s compliance with the Agreement and to Accurx’s ownership of the Platform, Products and underlying technology (in accordance with clause 11 of the Terms and Conditions), Licensee owns AI Outputs generated from its Authorised Use of AI Features, subject to paragraph 7.3
Licensee acknowledges that AI Outputs may not be unique and that the same or similar outputs may be generated for other customers or users. Nothing in this Schedule transfers to Licensee any rights in the Platform, AI Features, underlying technology, models, tools or other Intellectual Property Rights owned or licensed by Accurx.
Accurx shall maintain internal processes and policies for the validation of AI Outputs generated by AI Features, including processes to monitor the robustness, safety and accuracy of those features.
Accurx represents and warrants that it:
shall comply, and shall ensure that any sub-processors or AI providers engaged by Accurx comply, with all applicable laws relating to the design, development, use and provision of AI Features, including the Medical Device Legislation where applicable;
has obtained and will maintain all licences, consents and permissions necessary for the AI Features, including for Accurx to grant the rights and licences granted to Licensee under the Agreement; and
has incorporated privacy by design and by default into the development and operation of AI Features, including by completing and regularly reviewing Data Protection Impact Assessments.
Accurx shall promptly notify Licensee in writing if it becomes aware of any change in applicable law that would materially affect Accurx’s ability to provide AI Features in accordance with this Schedule.
The General Platform Disclaimer and the General AI Disclaimer apply to all AI Features. The relevant Product Specific Terms also apply to each AI Feature in addition to the General Platform Disclaimer and the General AI Disclaimer.
To the fullest extent permitted by law, Accurx shall not be liable for loss or damage arising from Licensee's or any Service Recipient's reliance on or use of AI Outputs, except to the extent caused by Accurx's breach of the Terms and Conditions (including this Schedule), the DPA, or the Medical Device Legislation.
Accurx's indemnity in clause 11.7 of the Terms and Conditions shall not apply to any claim arising from or relating to:
AI Inputs;
data or materials provided by or on behalf of Licensee or Service Recipients;
Licensee's or Service Recipients' use, modification or reliance on AI Outputs without appropriate human oversight;
failure by Licensee or Service Recipients to review or validate AI Outputs before use; or
allegations that AI Outputs are not unique or are the same as or similar to outputs generated for other customers.
Nothing in this Schedule limits any indemnity given by Licensee in the Agreement, including under clause 8.6 of the Terms and Conditions.
The following disclaimer applies to the use of all AI Features by Service Recipients and Authorised Users (“General AI Disclaimer”):
AI Features rely on machine learning and other artificial intelligence technologies that are inherently probabilistic and may produce output that is inaccurate, incomplete, is offensive or is not designed or intended to meet Licensee and any Service Recipient’s needs, expectations, or legal, regulatory, or compliance obligations.
Due to the nature of AI and machine learning technology, output may not be unique and the same or similar outputs may be generated for other customers. Accurx does not guarantee the accuracy, completeness or appropriateness of any output generated by AI Features.
Accordingly, Licensee and Service Recipients are solely responsible for:
reviewing, verifying and validating all AI-generated content and outputs before acting upon or saving them to any clinical, medical or patient record system;
developing and maintaining their own internal policies on the appropriate use of these technologies and the AI Features, and training Authorised Users or other relevant users on the same;
providing privacy notices and obtaining all necessary consents required by applicable laws;
implementing sufficient human oversight for the use of all AI Features; and
ensuring their use of AI Features complies with all applicable laws, regulations, professional standards and guidance, including those of any relevant regulatory or professional body (such as NHS England).
By using AI Features, Licensee acknowledges and agrees that Accurx is not responsible and accepts no liability for:
any inaccuracies, errors, omissions or limitations in the output from AI Features;
any biases, lack of fairness, or limitations of the underlying algorithms or data used by any AI Feature;
any output that Service Recipients or Authorised Users may find unsafe, harmful or offensive; or
any clinical decisions, actions or omissions made in reliance on the output of any AI Feature,
save to the extent caused by Accurx’s failure to adhere to its obligations under the Medical Device Legislation.
AI Features are optional features of the Platform and Service Recipients may stop using them at any time.
Scope and application: the following Product Specific Terms apply to the use of Accurx Scribe by Service Recipients and Authorised Users. This Schedule forms part of the Agreement and applies in addition to the General Platform Disclaimer and the General AI Disclaimer.
Scribe Provider: Accurx Scribe is provided by a third-party service (the "Scribe Provider") under this Agreement. For the purposes of Accurx Scribe, references to 'Accurx' in the General AI Disclaimer shall include 'the Scribe Provider'.
Medical Device: Accurx Scribe is a Medical Device and its Medical Device Information can be found within the Platform.
Intended use: Accurx Scribe is designed for use as a documentation aid only to assist with transcribing consultations and producing documentation. It is not to be used as a substitute for clinical diagnosis, treatment, or medical decision-making, all of which require skilled, professional human intervention and medical judgement or advice. Service Recipients and Authorised Users should only make decisions that they would be comfortable making without the feature.
Fair usage policy: Licensee acknowledges that Accurx Scribe is subject to fair usage limitations in order to prevent system overload, ensure service quality for all users and ensure licences are not being misused or shared between Authorised Users. Such usage limitations are based on the relevant access for Service Recipients as set out and accessible https://support.accurx.com/en/articles/4453468-accurx-lite-vs-accurx-plus-what-are-the-differences (as may be updated from time to time during the Term by Accurx). Usage exceeding this limit is not possible and no further transcriptions can be made by that Authorised User for the remainder of the day. There are no concurrency limits or incremental charges associated with this usage cap.
Accuracy and liability: Neither Accurx nor the Scribe Provider is responsible and/or liable for any errors, omissions, or inaccuracies in the transcriptions produced by, any unavailability of, or any misinformation or diagnosis arising from the use of Accurx Scribe, and cannot guarantee the accuracy of transcriptions.
Clinical responsibility: Service Recipient bears full responsibility for the final content added to any clinical, medical or patient record system.
Translation: Accurx Scribe is designed primarily for use by Service Recipients, Authorised Users and Patients with English as a first language. A translation feature is available within Accurx Scribe to assist Authorised Users undertaking consultations in a language other than English while documenting the consultation in English. This translation feature must not be used as a replacement for a professional interpretation service or interpreter. The accuracy of translation varies between available languages and the quality of the outputs in languages other than English may be reduced. All generated outputs must be checked for accuracy by an individual who understands both English and the language in which the consultation took place before being saved to any record system. Without this check, the accuracy of the output cannot be verified. Neither Accurx nor the Scribe Provider accepts liability for any misinformation or diagnosis caused by an incorrect or inaccurate translation arising from the use of the translation feature. Use of this translation feature is therefore entirely at the Service Recipients own option and risk.
Scope and application: the following Product Specific Terms apply to the use of Patient Initiated Forms and Accurx Navigator by Service Recipients and Authorised Users. This Schedule forms part of the Agreement and applies in addition to the General Platform Disclaimer.
Accurx Navigator availability: Accurx Navigator is a bolt-on to Patient Initiated Forms and is currently available to GPs only.
How Accurx Navigator works: Accurx Navigator is designed to educate and signpost Patients to additional information or services about their health issue during their journey of contacting their GP through the Platform. Accurx Navigator operates through automated matching technology to provide signposting options based on the health-related terms entered by a Patient, without clinical interpretation or input from Accurx or the Service Recipient.
Intended use and clinical responsibility: Patient Initiated Forms and Accurx Navigator are informational only and are not diagnostic tools. They do not provide medical advice, diagnosis or treatment recommendations and must not be used as a substitute for clinical diagnosis, treatment, or medical decision-making, all of which require skilled, professional human intervention and medical judgement or advice. Service Recipients, Authorised Users, and any other healthcare providers to which Patients are signposted within Accurx Navigator and Patient Initiated Forms, remain at all times solely responsible for the clinical care of their Patients.
Third-party content: Patient Initiated Forms and Accurx Navigator may use and show links to resources, advice and guidance that are provided by independent third parties (such as NHS England). These links may be selected by Accurx or configured by Service Recipients, Authorised Users and other local services or commissioners. Accurx takes reasonable steps to ensure the links selected are appropriate when added. Whilst Accurx may review links from time to time or in response to issues reported to it, Accurx cannot continuously monitor third-party content. Third-party content may change or become unavailable without notice to Accurx. Accurx cannot guarantee that all links remain current, complete, accurate or appropriate. Accurx does not create, control, endorse or assume any responsibility for any errors, omissions, or inaccuracies in, the completeness of or appropriateness of any the content, guidance, or advice that is within each link.
Configuration responsibility: Patient Initiated Forms and Accurx Navigator are configured and/or approved by Service Recipients, Authorised Users and other local services or commissioners, who assume full responsibility for all such configurations (such as pathways and linked resources) and any consequences arising from the use of those configurations. Service Recipients and Authorised Users remain solely responsible for reviewing, validating and approving all content and pathways before making them available to Patients. Service Recipients and Authorised Users acknowledge that external content may change without notice and should verify all information independently.
Supplementary service: Patient Initiated Forms and Accurx Navigator are supplementary to, not a replacement for, the provision of traditional healthcare services. Accordingly, Service Recipients and Authorised Users must always continue to offer alternative routes for Patients to access healthcare and regular clinical services alongside Patient Initiated Forms and Accurx Navigator (for example, GP appointments).
Scope and application: the following Product Specific Terms apply to the use of Accurx Mobile Directory by Service Recipients and Authorised Users. This Schedule forms part of the Agreement and applies in addition to the General Platform Disclaimer.
Intended use: Accurx Mobile Directory allows Authorised Users to access, view and update a directory of contact mobile numbers and email addresses within a hospital.
Public Content: Any information added to the Accurx Mobile Directory is publicly available to other Authorised Users accessing Accurx Mobile (“Public Content”), unless a Service Recipient requests that its Accurx Mobile Directory is kept private and appoints an administrator for its Accurx Mobile Directory. Each Authorised User is responsible for the Public Content that they post, including the legality, reliability and appropriateness of the Public Content.
Public Content use: Accurx does not supervise or moderate any Public Content and has no liability or responsibility for Public Content. Accurx reserves the right to remove or correct any Public Content. Service Recipients and Authorised Users acknowledge that Public Content will no longer be accessible if a Service Recipient has requested that Accurx keep its Accurx Mobile Directory private.
Authorised User obligations: by using Accurx Mobile Directory, each Authorised User agrees:
to respect the confidentiality of others, including colleagues and Patients;
that by posting Public Content they grant Accurx and Service Recipient (where relevant) the right and licence to use, modify, publicly perform, publicly display, reproduce and distribute it on and through Accurx Mobile, including making it available to other Authorised Users who may also use it subject to the AUP and these Product Specific Terms;
not to post any Public Content that violates the privacy rights, copyrights, contract rights or any other rights of any person, and to contact Accurx or the relevant Service Recipient if they are concerned about Public Content; and
not to establish any link in a way that suggests any form of association, approval or endorsement by Accurx where none exists.
Geographical use: Accurx Mobile is intended for use by people residing in the United Kingdom. If Authorised Free Users access Accurx Mobile from locations outside the United Kingdom, they are responsible for compliance with any applicable local laws.
Scope and application: the following Product Specific Terms apply to translation features used by Service Recipients and Authorised Users. This Schedule forms part of the Agreement and applies in addition to the General Platform Disclaimer.
Availability: translation features are currently available to a limited number of pilot sites only. Access is granted at Accurx's discretion and does not form part of the standard offering of the Platform.
Intended use: the Platform is designed primarily for use by Service Recipients, Authorised Users and Patients with English as a first language. Any translation service is provided using available third-party translation software.
Disclaimer: Accurx does not accept liability for any misinformation or diagnosis based on or caused by any incorrect or inaccurate translation arising from the use of such third-party translation software. Use of the translation service is therefore entirely at the Service Recipients’ own option and risk.
Scope and application: the following Product Specific Terms apply to the use of STQs by Service Recipients and Authorised Users. This Schedule forms part of the Agreement and applies in addition to the General Platform Disclaimer and the General AI Disclaimer.
Availability: STQs is a bolt-on to Patient Initiated Forms and is currently available to GPs only.
AI Feature and Medical Device: STQs is an AI Feature which uses third-party large language model technology to automatically generate follow-up questions based on the information submitted by a Patient. STQs is a Medical Device and its Medical Device Information can be found within the Platform.
Intended use: STQs is designed solely to assist with gathering additional information from Patients to support the clinical review process. It does not constitute triage, diagnosis or clinical decision-making and must not be treated as such. STQs must not be relied upon as a comprehensive clinical assessment tool as the follow-up questions generated are based on information provided by the Patient and are therefore dependent on the accuracy and completeness of that information. STQs does not replace the need for clinical review and judgement, and may generate questions that are inaccurate, incomplete, inappropriate or not relevant to the Patient's clinical needs.
Clinical responsibility: Service Recipients and Authorised Users are solely responsible for:
considering all clinically relevant factors before relying on any AI Output;
reviewing all information submitted by Patients in response to questions generated by AI, together with the original Patient submission, before any clinical decision is made; and
assessing the appropriateness of all information gathered through the feature before acting on it.
Disclaimer: to the extent STQs is not used in accordance with its Medical Device Information, Accurx accepts no liability for any inaccuracies, omissions or limitations in the questions generated by this feature. Accurx accepts no liability for any clinical decisions made in reliance on Patient responses to those questions.